StonvexLoading…
StonvexStonvexStonvexCore line items from SHEL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $266.89B | $284.31B | $316.62B | $381.31B |
Operating Income | $29.76B | $29.92B | $32.63B | $64.81B |
Net Income | $18.12B | $16.52B | $19.64B | $42.87B |
EPS (Diluted) | $3.00 | $2.53 | $2.85 | $5.71 |
Total Assets | $370.35B | $387.61B | $406.27B | $443.02B |
Total Liabilities | $195.03B | $207.44B | $217.91B | $250.43B |
Cash & Equivalents | $30.22B | $39.11B | $38.77B | $40.25B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | Not available | Not available | Not available |